Literature DB >> 22104067

Predicting the limits of cerebral autoregulation during cardiopulmonary bypass.

Brijen Joshi1, Masahiro Ono, Charles Brown, Kenneth Brady, R Blaine Easley, Gayane Yenokyan, Rebecca F Gottesman, Charles W Hogue.   

Abstract

BACKGROUND: Mean arterial blood pressure (MAP) targets are empirically chosen during cardiopulmonary bypass (CPB). We have previously shown that near-infrared spectroscopy (NIRS) can be used clinically for monitoring cerebral blood flow autoregulation. The hypothesis of this study was that real-time autoregulation monitoring using NIRS-based methods is more accurate for delineating the MAP at the lower limit of autoregulation (LLA) during CPB than empiric determinations based on age, preoperative history, and preoperative blood pressure.
METHODS: Two hundred thirty-two patients undergoing coronary artery bypass graft and/or valve surgery with CPB underwent transcranial Doppler monitoring of the middle cerebral arteries and NIRS monitoring. A continuous, moving Pearson correlation coefficient was calculated between MAP and cerebral blood flow velocity and between MAP and NIRS data to generate mean velocity index and cerebral oximeter index. When autoregulated, there is no correlation between cerebral blood flow and MAP (i.e., mean velocity and cerebral oximetry indices approach 0); when MAP is below the LLA, mean velocity and cerebral oximetry indices approach 1. The LLA was defined as the MAP at which mean velocity index increased with declining MAP to ≥ 0.4. Linear regression was performed to assess the relation between preoperative systolic blood pressure, MAP, MAP in 10% decrements from baseline, and average cerebral oximetry index with MAP at the LLA.
RESULTS: The MAP at the LLA was 66 mm Hg (95% prediction interval, 43 to 90 mm Hg) for the 225 patients in which this limit was observed. There was no relationship between preoperative MAP and the LLA (P = 0.829) after adjusting for age, gender, prior stroke, diabetes, and hypertension, but a cerebral oximetry index value of >0.5 was associated with the LLA (P = 0.022). The LLA could be identified with cerebral oximetry index in 219 (94.4%) patients. The mean difference in the LLA for mean velocity index versus cerebral oximetry index was -0.2 ± 10.2 mm Hg (95% CI, -1.5 to 1.2 mm Hg). Preoperative systolic blood pressure was associated with a higher LLA (P = 0.046) but only for those with systolic blood pressure ≤ 160 mm Hg.
CONCLUSIONS: There is a wide range of MAP at the LLA in patients during CPB, making estimation of this target difficult. Real-time monitoring of autoregulation with cerebral oximetry index may provide a more rational means for individualizing MAP during CPB.

Entities:  

Mesh:

Year:  2011        PMID: 22104067      PMCID: PMC3288415          DOI: 10.1213/ANE.0b013e31823d292a

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  36 in total

1.  Continuous monitoring of cerebrovascular autoregulation: a validation study.

Authors:  E W Lang; H M Mehdorn; N W C Dorsch; M Czosnyka
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

2.  Effects of pulsatile and nonpulsatile perfusion on cerebral hemodynamics investigated with a new pediatric pump.

Authors:  Akif Undar; Harald C Eichstaedt; Joyce E Bigley; Blake A Deady; Aimee E Porter; William K Vaughn; Charles D Fraser
Journal:  J Thorac Cardiovasc Surg       Date:  2002-08       Impact factor: 5.209

3.  Missing data: our view of the state of the art.

Authors:  Joseph L Schafer; John W Graham
Journal:  Psychol Methods       Date:  2002-06

4.  Cerebral autoregulation and flow/metabolism coupling during cardiopulmonary bypass: the influence of PaCO2.

Authors:  J M Murkin; J K Farrar; W A Tweed; F N McKenzie; G Guiraudon
Journal:  Anesth Analg       Date:  1987-09       Impact factor: 5.108

5.  Cerebral blood flow and cerebrovascular CO2 reactivity in stroke-age normal controls.

Authors:  S M Davis; R H Ackerman; J A Correia; N M Alpert; J Chang; F Buonanno; R E Kelley; B Rosner; J M Taveras
Journal:  Neurology       Date:  1983-04       Impact factor: 9.910

6.  Factors and their influence on regional cerebral blood flow during nonpulsatile cardiopulmonary bypass.

Authors:  A V Govier; J G Reves; R D McKay; R B Karp; G L Zorn; R B Morawetz; L R Smith; M Adams; A M Freeman
Journal:  Ann Thorac Surg       Date:  1984-12       Impact factor: 4.330

7.  Cerebral intravascular oxygenation correlates with mean arterial pressure in critically ill premature infants.

Authors:  M Tsuji; J P Saul; A du Plessis; E Eichenwald; J Sobh; R Crocker; J J Volpe
Journal:  Pediatrics       Date:  2000-10       Impact factor: 7.124

8.  Brain hyperperfusion during cardiac operations. Cerebral blood flow measured in man by intra-arterial injection of xenon 133: evidence suggestive of intraoperative microembolism.

Authors:  L Henriksen; E Hjelms; T Lindeburgh
Journal:  J Thorac Cardiovasc Surg       Date:  1983-08       Impact factor: 5.209

9.  Intracranial hypertension: what additional information can be derived from ICP waveform after head injury?

Authors:  M Balestreri; M Czosnyka; L A Steiner; E Schmidt; P Smielewski; B Matta; J D Pickard
Journal:  Acta Neurochir (Wien)       Date:  2004-02-02       Impact factor: 2.216

10.  Continuous monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral perfusion pressure in patients with traumatic brain injury.

Authors:  Luzius A Steiner; Marek Czosnyka; Stefan K Piechnik; Piotr Smielewski; Doris Chatfield; David K Menon; John D Pickard
Journal:  Crit Care Med       Date:  2002-04       Impact factor: 7.598

View more
  66 in total

1.  Risks for impaired cerebral autoregulation during cardiopulmonary bypass and postoperative stroke.

Authors:  M Ono; B Joshi; K Brady; R B Easley; Y Zheng; C Brown; W Baumgartner; C W Hogue
Journal:  Br J Anaesth       Date:  2012-06-01       Impact factor: 9.166

2.  Continuous cerebral blood flow autoregulation monitoring in patients undergoing liver transplantation.

Authors:  Yueying Zheng; April J Villamayor; William Merritt; Aliaksei Pustavoitau; Asad Latif; Ramola Bhambhani; Steve Frank; Ahmet Gurakar; Andrew Singer; Andrew Cameron; Robert D Stevens; Charles W Hogue
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

3.  You can't manage what you don't measure.

Authors:  Annelies Moerman; Anthony R Absalom
Journal:  J Clin Monit Comput       Date:  2015-10-14       Impact factor: 2.502

4.  The assessment of Buerger's exercise on dorsal foot skin circulation in patients with vasculopathic diabetic foot ulcer by using wireless near-infrared spectroscope: a cohort prospective study.

Authors:  Bor-Shyh Lin; Chang-Cheng Chang; Chun-Lin Su; Jhe-Ruei Li; Min-Ling Chen; Mei-Yen Chen; Yao-Kuang Huang
Journal:  Lasers Med Sci       Date:  2018-01-08       Impact factor: 3.161

5.  Targeting optimal blood pressure monitoring: what's next?

Authors:  André Y Denault; Patrice Brassard; Matthias Jacquet-Lagrèze; Antoine E Halwagi
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

Review 6.  Effects of anesthesia on cerebral blood flow, metabolism, and neuroprotection.

Authors:  Andrew M Slupe; Jeffrey R Kirsch
Journal:  J Cereb Blood Flow Metab       Date:  2018-07-16       Impact factor: 6.200

Review 7.  [Cerebral oximetry: clinical importance for cardiac surgery patients].

Authors:  J Schön; H Paarmann; M Heringlake
Journal:  Anaesthesist       Date:  2012-09-12       Impact factor: 1.041

8.  [Everything has its place: ideal location for cerebral oximetry].

Authors:  K Engelhard
Journal:  Anaesthesist       Date:  2012-11       Impact factor: 1.041

9.  Validation of a stand-alone near-infrared spectroscopy system for monitoring cerebral autoregulation during cardiac surgery.

Authors:  Masahiro Ono; Yueying Zheng; Brijen Joshi; Jeffrey C Sigl; Charles W Hogue
Journal:  Anesth Analg       Date:  2012-12-07       Impact factor: 5.108

Review 10.  [Perioperative stroke].

Authors:  M Fischer; U Kahl
Journal:  Anaesthesist       Date:  2021-01       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.